Comparison between Nuvoco Vistas IPO and Windlas Biotech IPO.
Nuvoco Vistas IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Windlas Biotech IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Nuvoco Vistas IPO is up to ₹5,000.00 Cr whereas the issue size of the Windlas Biotech IPO is up to ₹401.54 Cr. The final issue price of Nuvoco Vistas IPO is ₹570.00 per share and of Windlas Biotech IPO is ₹460.00 per share.
| Nuvoco Vistas IPO | Windlas Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹5 per share |
| Issue Price (Lower) | ₹560.00 per share | ₹448.00 per share |
| Issue Price (Upper) | ₹570.00 per share | ₹460.00 per share |
| Issue Price (Final) | ₹570.00 per share | ₹460.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 26 shares | 30 shares |
| Fresh Issue Size | 2,63,15,789 shares | 35,86,956 shares |
| Fresh Issue Size (Amount) | up to ₹1,500.00 Cr | up to ₹165.00 Cr |
| OFS Issue Size | 6,14,03,508 shares | 51,42,067 shares |
| OFS Issue Size (Amount) | up to ₹3,500.00 Cr | up to ₹236.54 Cr |
| Issue Size Total | 8,77,19,297 shares | 87,29,023 shares |
| Issue Size Total (Amount) | up to ₹5,000.00 Cr | up to ₹401.54 Cr |
Nuvoco Vistas IPO opens on Aug 09, 2021, while Windlas Biotech IPO opens on Aug 04, 2021. The closing date of Nuvoco Vistas IPO and Windlas Biotech IPO is Aug 11, 2021, and Aug 06, 2021, respectively.
| Nuvoco Vistas IPO | Windlas Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Aug 06, 2021 | Aug 03, 2021 |
| Issue Open | Aug 09, 2021 | Aug 04, 2021 |
| Issue Close | Aug 11, 2021 | Aug 06, 2021 |
| Basis Of Allotment (Tentative) | Aug 17, 2021 | Aug 11, 2021 |
| Initiation of Refunds (Tentative) | Aug 18, 2021 | Aug 12, 2021 |
| Credit of Share (Tentative) | Aug 20, 2021 | Aug 13, 2021 |
| Listing date (Tentative) | Aug 23, 2021 | Aug 16, 2021 |
| Anchor Lockin End date 1 | Sep 16, 2021 | Sep 10, 2021 |
| Anchor Lockin End date 2 | Nov 15, 2021 | Nov 09, 2021 |
Nuvoco Vistas IPO P/E ratio is , as compared to Windlas Biotech IPO P/E ratio of .
| Nuvoco Vistas IPO | Windlas Biotech IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 95.24 | 78 | ||||
| Promoter Shareholding (Post-Issue) | 71.03 | 65.16 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹20357.90 Cr. | ₹1002.54 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Nuvoco Vistas IPO Retail Individual Investors (RII) are offered 3,07,01,754 shares while in Windlas Biotech IPO retail investors are offered 3,07,01,754 shares. Qualified Institutional Buyers (QIB) are offered 1,75,43,860 shares in Nuvoco Vistas IPO and 17,45,804 shares in Windlas Biotech IPO.
| Nuvoco Vistas IPO | Windlas Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 2,63,15,788 shares | 26,18,706 shares |
| Market Maker Reservation | ||
| QIB | 1,75,43,860 shares | 17,45,804 shares |
| NII | 1,31,57,895 shares | 13,09,354 shares |
| RII | 3,07,01,754 shares | 30,55,159 shares |
| Employee | ||
| Others | ||
| Total | 8,77,19,297 shares | 87,29,023 shares |
Nuvoco Vistas IPO subscribed 1.71x in total, whereas Windlas Biotech IPO subscribed 22.44x.
| Nuvoco Vistas IPO | Windlas Biotech IPO | |
|---|---|---|
| QIB (times) | 4.23x | 24.40x |
| NII (times) | 0.66x | 15.73x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.73x | 24.22x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.71x | 22.44x |
